{"url":"https://lda.senate.gov/api/v1/filings/4470bb21-90be-4e16-bbd2-e7cf258cd7f2/","filing_uuid":"4470bb21-90be-4e16-bbd2-e7cf258cd7f2","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/4470bb21-90be-4e16-bbd2-e7cf258cd7f2/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Brian Tse","dt_posted":"2026-07-20T13:06:34-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1717 K St., NW","registrant_address_2":"Suite 900","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401004840,"url":"https://lda.senate.gov/api/v1/registrants/401004840/","house_registrant_id":null,"name":"THE CONAFAY GROUP, LLC","description":"Life Sciences Consulting Firm","address_1":"1001 Pennsylvania Ave, NW","address_2":"13th Floor North","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ERICA WOODWARD","contact_telephone":"+1 859-229-7237","dt_updated":"2026-01-30T10:00:55.918324-05:00"},"client":{"id":73508,"url":"https://lda.senate.gov/api/v1/clients/73508/","client_id":73508,"name":"KIRIN BIOMATERIALS","general_description":"Pharmaceutical company.","client_government_entity":null,"client_self_select":false,"state":null,"state_display":null,"country":"JP","country_display":"Japan","ppb_state":null,"ppb_state_display":null,"ppb_country":"JP","ppb_country_display":"Japan","effective_date":"2026-06-10"},"lobbying_activities":[{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Support for the manufacture of bulk pharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64541,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"P.","last_name":"PAWELCZYK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153644,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"TSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143511,"prefix":null,"prefix_display":null,"first_name":"BRYAN","nickname":null,"middle_name":null,"last_name":"SHUY","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmteon Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst.Secretary for Preparedness and Response (ASPR)","new":false},{"lobbyist":{"id":151392,"prefix":null,"prefix_display":null,"first_name":"EVANGELINE","nickname":"EVIE","middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}